104 related articles for article (PubMed ID: 4172726)
21. Large scale production of human plasma fractions. Eight years experience with the alcohol fractionation procedure of Nitschmann, Kistler and Lergier.
KISTLER P; NITSCHMANN H
Vox Sang; 1962; 7():414-24. PubMed ID: 14033119
[No Abstract] [Full Text] [Related]
22. [Hemotherapy in malignant hematologic diseases].
Marti HR
Schweiz Med Wochenschr; 1975 Jun; 105(24):778-9. PubMed ID: 49923
[TBL] [Abstract][Full Text] [Related]
23. [Experiences at the Blood Transfusion Center of the Socialist Republic of Serbia in providing aimed transfusions].
Dordević Z; Baklaja R; Gligorović V; Skendzić N; Krivokapić L; Cvetković V; Stajić M
Bilt Hematol Transfuz; 1975; 3(1-2):11-9. PubMed ID: 57772
[TBL] [Abstract][Full Text] [Related]
24. [The therapeutic use of stored blood and blood substitutes indications and contraindications].
Pazderski H
Wiad Lek; 1969 Jan; 22(1):19-24. PubMed ID: 4182544
[No Abstract] [Full Text] [Related]
25. [Plasma proteins in donors after single transfusion and after multiple transfusion(Normal values)].
Smálik S; Milar A
Vnitr Lek; 1971 Jul; 17(7):631-6. PubMed ID: 4105127
[No Abstract] [Full Text] [Related]
26. When should we use blood or blood components?
Knouse CA
J Am Osteopath Assoc; 1977 Apr; 76(8):633, 635-9 concl. PubMed ID: 408391
[No Abstract] [Full Text] [Related]
27. [HEMOSTATIC TRANSFUSION PREPARATIONS PREPARED FROM DONOR BLOOD (ANTIHEMOPHILIC PLASMA, ANTIHEMOPHILIC GLOBULIN, FIBRINOGEN)].
ROZENBERG GIa; RUDNITSKAIA MZ
Probl Gematol Pereliv Krovi; 1963 Jun; 8():3-9. PubMed ID: 14070543
[No Abstract] [Full Text] [Related]
28. The clinical use of plasma fractions.
Hässig A
Haematologia (Budap); 1974; 8(1-4):393-400. PubMed ID: 4142622
[No Abstract] [Full Text] [Related]
29. New trends in plasma fractionation.
Steinbuch M
Haematologia (Budap); 1983; 16(1-4):39-51. PubMed ID: 6207083
[No Abstract] [Full Text] [Related]
30. [Various problems in the use of constituents of the blood: from the Symposium of the 18th Congress of the Japanese Association of Medical Sciences].
Murakami S; Kagami M; Abe H; Hasegawa Y; Torii A
Nihon Ishikai Zasshi; 1971 Jul; 66(2):143-60. PubMed ID: 4106494
[No Abstract] [Full Text] [Related]
31. Acquired inhibitors of coagulants.
Bidwell E
Annu Rev Med; 1969; 20():63-74. PubMed ID: 4183761
[No Abstract] [Full Text] [Related]
32. A study of the chemical and clinical qualities of serum albumin and serum gamma globulin prepared from human blood more than twenty-one days old.
MULFORD DJ; DWYER RC
Am J Public Health Nations Health; 1950 Jun; 40(6):691-6. PubMed ID: 15413711
[No Abstract] [Full Text] [Related]
33. Blood component therapy in neonatal medicine.
Lenes BA; Sacher RA
Clin Lab Med; 1981 Jun; 1(2):285-309. PubMed ID: 6809397
[No Abstract] [Full Text] [Related]
34. Plasma fractionation in blood transfusion service.
Haskó F; Salamon M; Bartha K; Dobó P
Dev Biol Stand; 1987; 67():39-48. PubMed ID: 3111912
[TBL] [Abstract][Full Text] [Related]
35. The physiologic variations of some plasma components after closed fractures.
Herold HZ; Weissman SL; Hertzberg M; Oberman Z
Clin Orthop Relat Res; 1968; 57():299-302. PubMed ID: 4174647
[No Abstract] [Full Text] [Related]
36. Rational alternatives to the use of whole blood.
Westphal RG
Ann Intern Med; 1972 Jun; 76(6):987-90. PubMed ID: 5027586
[No Abstract] [Full Text] [Related]
37. The immunological properties of factor VIII. II. The immunoelectrophoretic studies.
Uszyński L
Thromb Diath Haemorrh; 1967 Dec; 18(3-4):325-31. PubMed ID: 4173213
[No Abstract] [Full Text] [Related]
38. [Study of the viscosity of albumin, gamma globulin and fibrinogen solutions].
Gaillard S; Rovel A; Vigneron C; Stoltz JF; Larcan A; Streiff F
C R Seances Soc Biol Fil; 1974; 168(8-9):1072-7. PubMed ID: 4142600
[No Abstract] [Full Text] [Related]
39. [Analysis of lytic effect on fibrin of immobilized heparin in complex with plasma proteins].
Platé NA; Valuev LI; Gumirova FKh; Maklakova IA
Vopr Med Khim; 1982; 28(5):19-23. PubMed ID: 6217639
[TBL] [Abstract][Full Text] [Related]
40. Investigations on the interaction of 2-methoxy-5-chloro-procainamide (metoclopramide) with serum proteins.
Pagnini G; Di Carlo R
Arzneimittelforschung; 1972 Apr; 22(4):780-3. PubMed ID: 4114976
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
